tradingkey.logo
搜索

Bionano Genomics Inc

BNGO
添加自选
1.150USD
-0.020-1.71%
收盘 07/02, 13:00美东报价延迟15分钟
12.35M总市值
亏损市盈率 TTM

关于 Bionano Genomics Inc 公司

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Inc简介

公司代码BNGO
公司名称Bionano Genomics Inc
上市日期Aug 01, 2018
CEOHolmlin (R. Erik)
员工数量98
证券类型Ordinary Share
年结日Aug 01
公司地址9540 Towne Centre Drive
城市SAN DIEGO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编92121
电话18588887600
网址https://bionano.com/
公司代码BNGO
上市日期Aug 01, 2018
CEOHolmlin (R. Erik)

Bionano Genomics Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

常见问题

Bionano Genomics Inc的前五大股东是谁?

Bionano Genomics Inc 的前五大股东如下:Mr. Mark Oldakowski

有多少机构持有Bionano Genomics Inc(BNGO)的股份?

截至2026Q1,共有109家机构持有Bionano Genomics Inc的股份,合计持有的股份价值约为1.17M,占公司总股份的10.52%。与2025Q4相比,机构持股有所增加,增幅为32263.00。

哪个业务部门对Bionano Genomics Inc的收入贡献最大?

在2026Q1,Consumables业务部门对Bionano Genomics Inc的收入贡献最大,创收13.97M,占总收入的49.00%。